Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Mechanisms of Drug Action and Receptors
1. Pharmacodynamics -
Mechanism of drug action and their
Receptor
Presented by-
ARCHITA SRIVASTAVA
M.PHARM 1ST YEAR
Department of pharmacology
2. CONTENTS
Principle of drug action
Mechanism of drug action
Receptor
Drug receptor interaction
Types of receptors
Working of receptors
Reference
3. Drug do not impart new function to any system , organ
or cell , they only alter the pace of ongoing activity.
Types of drug action -
• Stimulation
• Depression
• Irritation
• Replacement
• Cytotoxic action
Principles of Drug Action
4. Mechanism of Drug Action
Receptor mediate Non receptor mediate
GPCR By physical action
Ligand gated ion channel By chemical action
Enzymatic receptor By ion channel
Nucleus receptor By enzymes
By transporters
6. Several substrates are translocated across membranes
by binding to specific transporters (carriers) which either facilitate
diffusion in the direction of the concentration gradient or pump
the metabolite/ion against the concentration gradient using
metabolic energy
Mechanism of Drug Action- Transporters
7. Receptor are macromolecules present either on the cell surface ,
cytoplasm or in the nucleus with which the drug binds and
interact to produce cellular response.
Receptor are protein in nature.
Mechanism of Drug Action-Receptors
8. Agonist- An agent which activates a receptor to
produce an effect similar to that of the physiological
signal molecule
Inverse agonist- An agent which activates a receptor
to produce an effect in the opposite direction to that of
the agonist.
Antagonist- An agent which prevents the action of
an agonist on a receptor or the subsequent response, but
does not have any effect of its own.
Partial agonist- An agent which activates a receptor
to produce submaximal effect but antagonizes the
action of a full agonist.
Mechanism of Drug Action- Drug –Receptor
Interaction
9. Agonist- have both affinity and maximal intrinsic
activity (IA = 1), e.g. adrenaline.
Inverse agonist- have affinity but intrinsic activity with
a minus sign (IA between 0 and -1), e.g. DMCM (on
benzodiazepine receptor).
Antagonist- have affinity but no intrinsic activity
(IA = 0), e.g. propranolol.
Partial agonist- have affinity and submaximal intrinsic
activity (IA between 0 and 1), e.g. pentazocine (on µ
opioid receptor).
Mechanism of Drug Action- Drug –Receptor
Interaction
10. Occupation of a receptor by a drug molecule may or may not result in
activation of the receptor. By activation, we mean that the receptor is affected
by the bound molecule in such a way as to alter the receptor’s behaviour
towards the cell and elicit a tissue response. The molecular mechanisms
associated with receptor activation are
Mechanism of Drug Action- Drug-Receptor
Interaction
11. Mechanism of Drug Action-
1.G Protein Coupled Receptor
These are sometimes called metabotropic or seven-trans membrane domain
(7-TDM) receptors
Structures comprise seven membrane-spanning α-helices, often linked as
dimeric structures
The third intracellular loop interacts with the G protein
The G protein is a membrane protein comprising three subunits (α, β, γ),
the α subunit possessing GTPase activity
When the trimer binds to an agonist-occupied receptor, the α subunit binds
GTP, dissociates and is then free to activate an effector (e.g. a membrane
enzyme)
12. The α- subunits into four families:
Gs
Adenyl cyclase
activation
Increased
cAMP
Gi
Adenyl cyclase
inhibition
Decreased
cAMP
Gq
Phosholipase
C
Increased IP
&DAG
Go
Calcium
channel
inhibition
13. Mechanism of Drug Action-
Cytoplasmic Secondary messengers
Binding of an agonist to a receptor provides the first
message in receptor signal transduction to effectors to
affect cell physiology. The first messenger promotes the
cellular production or mobilization of a second
messenger, which initiates cellular signaling through a
specific biochemical pathway.
Cyclic AMP
Cyclic GMP
Ca2+
inositol Phosphate
Diacyl Glycerol
NO
16. MECHANISM OF ACTION – GPCR
III. CHANNEL REGULATION
The activated G- protein [Gs, Gi, Go] can also open or
inhibit ionic channel specific for Ca⁺⁺ and K⁺, without the
intervention of any second messenger like cAMP or IP3
and bring about hyperpolarization/depolarization
/changes in intracellular Ca⁺⁺ ion.
Direct channel regulation is mostly the function of the βγ
dimer of the dissociated G- protein
17. Mechanism of Drug Action-
2.Receptor with Ligand gated ion channel
• These are sometimes called ionotropic
receptors
• They are involved mainly in fast synaptic
transmission
• There are several structural families, the
commonest being heteromeric assemblies
of four or five subunits, with
transmembrane helices arranged around a
central aqueous channel
• Ligand binding and channel opening
occur on a millisecond timescale
• Examples include the nicotinic
acetylcholine, GABA type A (GABAA),
glutamate (NMDA) and ATP (P2X)
receptors
18. Mechanism of Drug Action-
3.Enzyme linked receptors
A) Intrinsic tyrosine protein kinase receptor
B) JAK- STAT Kinase binding receptor
21. REFERANCE -
1. Tripathi K.D, ‘ Essential of Medicinal Pharmacology’’ ,
Jaypee brothers medical publishers , 2015 , seventh
edition , Page no 47-56
2. Rang & Dale’s ‘PHARMACOLOGY’ eighth edition
3. Shanbhag T.V ,etal , “Pharmacology – preparation
manual ” , Reed Elsevier India privet limited, 2014, 2nd
edition no 26-28
Editor's Notes
BZD-agonists enhance GABA induced hyperpolarization (due to influx of Cl- ions), and decrease firing rate of neurones, other compounds called BZD-inverse agonists like
dimethoxyethyl-carbomethoxy- -carboline
(DMCM) inhibit GABA action and are convulsants.
BZD-agonists enhance GABA induced hyperpolarization (due to influx of Cl- ions), and decrease firing rate of neurones, other compounds called BZD-inverse agonists like
dimethoxyethyl-carbomethoxy- -carboline
(DMCM) inhibit GABA action and are convulsants.
BZD-agonists enhance GABA induced hyperpolarization (due to influx of Cl- ions), and decrease firing rate of neurones, other compounds called BZD-inverse agonists like
dimethoxyethyl-carbomethoxy- -carboline
(DMCM) inhibit GABA action and are convulsants.